Commentary
Commentary
Pharmaceutical Tariffs Will Have Horrific Side Effects
President Trump implemented a raft of tariffs this week. All imports are subject to a 10% import duty. Those from China are subject to a 145% tariff. Pharmaceuticals appear to be exempt from the tariffs — for now. Drug manufacturers expect to get hit with tariffs at some point; they’re ...
Commentary
Here’s what “radical transparency” on health care can look like
“Radical transparency” has become a favorite phrase of the Trump administration. The president recently signed an executive order that aims to “empower patients with clear, accurate, and actionable pricing information.” If hospitals and insurers comply — and that’s a big if — patients will finally be able to shop for ...
Commentary
Congress Ought To Dismantle The Healthcare Deep State
One senior Department of Government Efficiency (DOGE) staffer is reportedly trying to shield the Center for Medicare and Medicaid Innovation (CMMI) from mass layoffs and budget cuts, according to a recent Politico expose. That’s a shame. If there’s any agency in Washington that deserves to be cut to the bone—or ...
Commentary
The Private Sector Is Setting The PACE For Managed Care
Rising demand for long-term care is inevitable as more and more baby boomers retire. Meeting this demand will be a challenge. Recent evidence from the PACE program demonstrates that for-profit care providers can help meet this growing demand, but only if the regulatory environment allows it. Read the op-ed here.
Commentary
Medicaid reform is popular
Congressional Republicans keep dodging questions about cuts to Medicaid, the federal-state entitlement that covers nearly 80 million people. But they should not be shy about their plans to reform the entitlement. New polling shows that many of the GOP’s ideas for Medicaid aren’t just smart policy. They’re popular. A survey ...
Business & Economics
An economist explains what trade deficits really mean
Believing the myth that trade deficits are bad, the Trump Administration imposed global reciprocal tariffs this week. The proposal threatens to derail economic prosperity and trigger a barn burner of a recession. The fallacy of this myth can be clearly seen in the U.S. economic data. Over the last half-century ...
Commentary
Price Controls Won’t End Global Pharma Freeloading
A new paper by the America First Policy Institute, a think tank with close ties to the Trump administration, has revived the debate over global drug pricing. The paper points out that patients in the United States tend to pay considerably more for brand-name prescription drugs than those in most ...
Business & Economics
Louisiana Is Litigating Away Its Economic Prosperity
Numerous Louisiana parishes are suing oil and gas companies over coastal erosion. A Plaquemines Parish courtroom has a front row seat to one of the more high-dollar cases taking place where the plaintiffs have reportedly asked for more than $3 billion in damages from just one of the defendants. Undoubtedly ...
Commentary
Here’s How Trump’s Pick To Lead The FDA Can Supercharge The Agency
The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug Administration. During his confirmation hearing, Makary said his goals for the agency were “more cures and meaningful treatments for Americans.” Throughout the hearing, he offered insight on how he ...
Business & Economics
Reversing Regulatory Overreach Will Encourage Payment Innovations
Innovation is often a victim of its own success as the once unimaginable becomes the invaluable service people cannot live without. The modern payments system exemplifies this phenomenon. Innovations by fintech startups as well as traditional financial companies now enable trillions of dollars in transactions annually. And thanks to robust ...
Pharmaceutical Tariffs Will Have Horrific Side Effects
President Trump implemented a raft of tariffs this week. All imports are subject to a 10% import duty. Those from China are subject to a 145% tariff. Pharmaceuticals appear to be exempt from the tariffs — for now. Drug manufacturers expect to get hit with tariffs at some point; they’re ...
Here’s what “radical transparency” on health care can look like
“Radical transparency” has become a favorite phrase of the Trump administration. The president recently signed an executive order that aims to “empower patients with clear, accurate, and actionable pricing information.” If hospitals and insurers comply — and that’s a big if — patients will finally be able to shop for ...
Congress Ought To Dismantle The Healthcare Deep State
One senior Department of Government Efficiency (DOGE) staffer is reportedly trying to shield the Center for Medicare and Medicaid Innovation (CMMI) from mass layoffs and budget cuts, according to a recent Politico expose. That’s a shame. If there’s any agency in Washington that deserves to be cut to the bone—or ...
The Private Sector Is Setting The PACE For Managed Care
Rising demand for long-term care is inevitable as more and more baby boomers retire. Meeting this demand will be a challenge. Recent evidence from the PACE program demonstrates that for-profit care providers can help meet this growing demand, but only if the regulatory environment allows it. Read the op-ed here.
Medicaid reform is popular
Congressional Republicans keep dodging questions about cuts to Medicaid, the federal-state entitlement that covers nearly 80 million people. But they should not be shy about their plans to reform the entitlement. New polling shows that many of the GOP’s ideas for Medicaid aren’t just smart policy. They’re popular. A survey ...
An economist explains what trade deficits really mean
Believing the myth that trade deficits are bad, the Trump Administration imposed global reciprocal tariffs this week. The proposal threatens to derail economic prosperity and trigger a barn burner of a recession. The fallacy of this myth can be clearly seen in the U.S. economic data. Over the last half-century ...
Price Controls Won’t End Global Pharma Freeloading
A new paper by the America First Policy Institute, a think tank with close ties to the Trump administration, has revived the debate over global drug pricing. The paper points out that patients in the United States tend to pay considerably more for brand-name prescription drugs than those in most ...
Louisiana Is Litigating Away Its Economic Prosperity
Numerous Louisiana parishes are suing oil and gas companies over coastal erosion. A Plaquemines Parish courtroom has a front row seat to one of the more high-dollar cases taking place where the plaintiffs have reportedly asked for more than $3 billion in damages from just one of the defendants. Undoubtedly ...
Here’s How Trump’s Pick To Lead The FDA Can Supercharge The Agency
The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug Administration. During his confirmation hearing, Makary said his goals for the agency were “more cures and meaningful treatments for Americans.” Throughout the hearing, he offered insight on how he ...
Reversing Regulatory Overreach Will Encourage Payment Innovations
Innovation is often a victim of its own success as the once unimaginable becomes the invaluable service people cannot live without. The modern payments system exemplifies this phenomenon. Innovations by fintech startups as well as traditional financial companies now enable trillions of dollars in transactions annually. And thanks to robust ...
